Clinical Trial

Effects of Empagliflozin-Metformin, Sitagliptin-Metformin, and Metformin on Adipokines in Type 2 Diabetes

Completed Phase 4
View on ClinicalTrials.gov →
Summary
This study compared the impacts of empagliflozin-metformin, sitagliptin-metformin, and metformin monotherapy in treatment-naive overweight or obese adults with newly diagnosed type 2 diabetes mellitus in Erbil, Iraq. The study monitored participants for 12 weeks. It determined changes in serum omentin-1, resistin, glycemic markers, and anthropometric measures.
Trial Details
NCT Number NCT07531108
Lead Sponsor Hawler Medical University
Conditions Diabetes Mellitus, Type 2
Enrollment 186 participants
Start Date 2024-11-15
Primary Completion 2025-11-27 (estimated)
Study Completion 2025-11-27 (estimated)
Updated on ClinicalTrials.gov 2026-04-15